SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications | BioSpace Source Cluster: BioSpace Source Node: 3053353Time Stamp: Jan 8, 2024
The Other Side of the Schedule 3 Story – Former DEA Official Leaks What Could Happen to the Marijuana Industry Source Cluster: CannabisNet Source Node: 3051264Time Stamp: Jan 6, 2024
U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum Source Cluster: Fintech News Source Node: 3049508Time Stamp: Jan 5, 2024
Signal: FTC granted injunction to pause IQVIA’s acquisition of Propel Media Source Cluster: Medical Device Network Source Node: 3045068Time Stamp: Jan 3, 2024
Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next Source Cluster: Singularity Hub Source Node: 3044524Time Stamp: Jan 3, 2024
CHMP Q&A Document on Development and Assessment for Companion Diagnostic Products | CHMP Source Cluster: Reg Desk Source Node: 3043437Time Stamp: Jan 2, 2024
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval | BioSpace Source Cluster: BioSpace Source Node: 3043191Time Stamp: Jan 1, 2024
The US Federal Government is Spending $10 Million to Study the Effects of Medical Marijuana on People Source Cluster: CannabisNet Source Node: 3044742Time Stamp: Jan 1, 2024
How Many People Would Try Shrooms If They Were Legal? – Over 700 People Bought Legal Psilocybin in Oregon in 2023 Source Cluster: CannabisNet Source Node: 3044744Time Stamp: Jan 1, 2024
Intracerebral fate of organic and inorganic nanoparticles is dependent on microglial extracellular vesicle function – Nature Nanotechnology Source Cluster: Nature Nanotechnology Source Node: 3041108Time Stamp: Dec 29, 2023
Astra Boosts Push Into China Biotech Scene With $1.2B Buy Source Cluster: Supply Chain Brain Source Node: 3039104Time Stamp: Dec 29, 2023
FDA Guidance on Assessing the Credibility of Computational Modeling and Simulation: Credibility Evidence Part 2 | FDA Source Cluster: Reg Desk Source Node: 3038380Time Stamp: Dec 28, 2023
SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury | BioSpace Source Cluster: BioSpace Source Node: 3039348Time Stamp: Dec 27, 2023
Transforming Health and Longevity with Rejuve’s AI and Blockchain Source Cluster: CryptoCoin News Source Node: 3036785Time Stamp: Dec 27, 2023
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors | BioSpace Source Cluster: BioSpace Source Node: 3038279Time Stamp: Dec 26, 2023
CRISPR Gene Editing Had a Breakthrough Year—and It’s Only Getting Started Source Cluster: Singularity Hub Source Node: 3037017Time Stamp: Dec 26, 2023
Signal: Lilly searches for new obesity drugs in partnership with Fauna Bio Source Cluster: Medical Device Network Source Node: 3032462Time Stamp: Dec 22, 2023
Alcresta obtains approval for new digestive enzyme cartridge Source Cluster: Medical Device Network Source Node: 3030811Time Stamp: Dec 22, 2023
The Future of AI: Capitalising the value of proprietary data | EU-Startups Source Cluster: EU-Startups Source Node: 3032842Time Stamp: Dec 22, 2023
AI Discovers a New Class of Antibiotics After Scouring 12 Million Compounds Source Cluster: Singularity Hub Source Node: 3030857Time Stamp: Dec 21, 2023